Your browser doesn't support javascript.
loading
Successful use of intrapelvic Quikclot in life-threatening blast injury.
Goddard, Naveen Virin; Evriviades, Demetrius.
Afiliação
  • Goddard NV; College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.
  • Evriviades D; Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, B15 2TH, United Kingdom.
Trauma Case Rep ; 12: 59-62, 2017 Dec.
Article em En | MEDLINE | ID: mdl-29644287
ABSTRACT
Patients that suffer multiple traumatic injuries often present with uncontrollable haemorrhage and rapidly descend into a viscous death triad consisting of hypothermia, coagulopathy and acidosis. Initial surgical intervention does not aim to provide conclusive repair, but instead strives to stop blood loss while priority is given to correct the patient's metabolic state (Duchesne et al., 2010). However in some cases of massive polytrauma, gaining surgical control of bleeding can be incredibly difficult. As a result a number of topical haemostatic agents were developed for use in military and civilian settings. This case details a successful intracavity use of the granular haemostatic agent, Quikclot™ (Z-Medica), in halting massive haemorrhage in a patient who sustained major blast injuries. Although not officially recommended, intracorporeal uses of Quikclot™ can be effective as a last resort in preventing loss of life in cases of severe polytrauma. However, users need to remain wary of complications which may arise due to its application.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Trauma Case Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Trauma Case Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido